FDA recall D-0324-2020

Sato Pharmaceutical Inc. · Class III · drug

Product

WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,

Reason for recall

Subpotent Drug

Distribution

Nationwide within the United States, Guam and Saipan

Key facts

Status
Terminated
Initiation date
2019-10-01
Report date
2019-11-20
Termination date
2020-08-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Torrance, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0324-2020